Issue 2: January 2018

Our Mission
The ICRN is a global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share the passion to make significant scientific advances that improve outcomes for patients with cholangiocarcinoma.

ICRN Participating Centers

U.S. Centers
  • Banner Health
  • Emory University
  • Fred Hutchinson Cancer Research Center
  • Johns Hopkins University
  • Massachusetts General Hospital 
  • Mayo Clinic
  • MD Anderson Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • University California San Francisco
  • University of Michigan
  • University of Utah
  • Vanderbilt University
  • Virginia Mason Medical Center
  • Yale University
International Centers
  • Chulalongkorn University [Thailand]
  • National Health Research Institutes, Kaoshsiung Medicine University [Taiwan]
  • Pusan National Hospital
  • Siriraj Hospital [Thailand]
  • University College London Hospital [UK]
  • University of Amsterdam [Netherlands]
  • University of Calgary [Canada]
  • University of Nottingham [UK]

We would like to welcome our newest ICRN participating centers
  • Christie NHS Foundation Trust
  • Cleveland Clinic Foundation
  • Hacettepe University cancer Institute [Turkey]
  • Hepatobiliary Medical Society Returned Scholar Association [China]
  • Peking Union Medical College Hospital [China]
  • Princess Margaret Hospital [Canada]
  • University of Southern California
  • University of Washington

ICRN Working Groups
The ICRN Working Groups help us to better coordinate our research efforts.
  • Leadership: Dr. Milind Javle and Dr. Mitesh Borad provide overall direction of the ICRN including clinical trials, Industry Forum, Asia-Pacific Conference, and publications.
  • Surgical: Dr. Yun Shin Chun and Dr. Flavio Rocha spearhead efforts in surgical translational research.
  • Clinical Research: Dr. Laura Goff leads the clinical data sharing for collaborative research.
  • Genomic Research: Dr. Lipika Goyal leads genomic research initiatives.
  • International collaboration: Dr. John Bridgewater and Dr. Virote Sriuranpong recruit Asian, European and other international centers for collaborative research.
  • Biorepository: Dr. Lewis Roberts and Dr. Milind Javle coordinate the ICRN tissue and blood banking repository.
  • Administration: Dr. Reham Abdel-Wahab and Donna Mayer provide oversight of budgets, grants, meetings, ICRN website and newsletters.
We welcome your participation in the Working Groups of your choice.
Email Dr. Reham Abdel-Wahab at for more information.

ICRN Executive Committee
Chair: Milind Javle, MD
Gastrointestinal Medical Oncology Department
MD Anderson Cancer Center

Reham Abdel-Wahab, MD, PhD
ICRN Associate Program Director

Melinda Bachini

Advocacy Director
Cholangiocarcinoma Foundation

Dr. John Bridgewater, MRCP, PhD
Medical Oncology Department
University College London Hospitals

Yun Shin Chun, MD, FACS
Surgical Oncology Department
MD Anderson Cancer Center  

Laura Goff, MD
Hematology/Oncology Department
Vanderbilt Ingram Cancer Center  

Lipika Goyal, MD
Hematology/Oncology Department
Massachusetts General Hospital

Shishir K. Maithel, MD, FACS
Department of Surgery
Emory University School of Medicine

Vice-Chair: Mitesh Borad, MD
Medical Oncology Department
Mayo Clinic  

Donna Mayer
ICRN Program Director
Cholangiocarcinoma Foundation

Stacie Lindsey

President and Founder,
Cholangiocarcinoma Foundation

Judith McBrien
Patient Advocate
Cholangiocarcinoma Foundation

Flavio G. Rocha, MD, FACS Hepatopancreatobiliary Service
Virginia Mason Medical Center  

Lewis Roberts, MB, ChB, PhD
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic  

Virote Sriuranpong, MD, PhD
Medical Oncology Department
Chulalongkorn University

Dr. Shishir K. Maithel
We would like to welcome our newest ICRN Executive Committee Member - Dr. Shishir K. Maithel, MD, FACS. He is an Associate Professor of Surgery in the Division of Surgical Oncology, Department of Surgery at Emory University School of Medicine. As Scientific Director of the Emory Liver and Pancreas Center, he leads the clinical / translational research program in the Division of Surgical Oncology, which focuses on identifying tumor specific molecular biomarkers as predictors of outcome and chemotherapeutic response for hepatobiliary tumors. Dr. Maithel is also Director and National Principal Investigator of the U.S. Extrahepatic Biliary Malignancy Consortium, and is an active member and study lead in the Central Pancreas Consortium.

Save the Date
We welcome your participation in these important meetings.

ICRN Member Meeting at GI ASCO
Friday, January 19

InterContinental Hotel - Telegraph Room
888 Howard Street, San Francisco

Click here to RSVP

5th Cholangiocarcinoma Foundation Annual Conference
January 31-February 2
Marriott at City Creek, Salt Lake City, Utah
Visit the Conference Website

ICRN Meeting
Thursday, February 1
Cottonwood Room, 1st Floor

ICRN Industry Forum(s)
Thursday, February 1 and Friday, February 2
Brighton Room, 2nd Floor
Click here to RSVP

2nd Asia-Pacific Congress
March 23-24, 2018
Siriraj University Hospital, Bangkok
Chaired by Mitesh Borad, MD(Mayo Clinic) and
Charuwan Akewanlop, MD (Siriraj Hospital, Thailand)
Visit the Conference Website

©2006-2017 All Rights Reserved, The Cholangiocarcinoma Foundation
5526 West 13400 South, #510, Herriman, Utah 84096, U.S.A.
(888) 936-6731